[BIO] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[BIO] Bio-Rad Laboratories, Inc.
Announcement Date
17-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -185.27%
Quarter Report
BIO's Result
BIO's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 2,671,262 2,802,249 2,922,545 2,545,626 2,311,659 2,290,109 2,160,153 3.60%
PBT -850,104 -4,704,273 5,438,149 4,907,638 2,261,081 507,359 97,805 -
Tax -212,780 -1,076,738 1,192,247 1,101,371 502,406 146,363 -16,935 52.44%
NP -637,324 -3,627,535 4,254,257 3,814,229 1,758,675 360,996 114,740 -
Tax Rate - - -21.92% -22.44% -22.22% -28.85% 17.32% -
Total Cost 3,308,586 6,429,784 -1,331,712 -1,268,603 552,984 1,929,113 2,045,413 8.34%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -23.86 -129.45 145.57 149.83 76.08 15.76 5.31 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -21.82 -121.79 142.61 127.86 58.93 12.10 4.12 -
EPS Diluted -21.82 -121.79 140.83 126.20 58.27 11.94 4.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.